Categories Earnings Calls, Health Care

Merck & Co Inc (MRK) Q4 2020 Earnings Call

Merck & Co Inc  (NYSE: MRK) Q4 2020 earnings call dated Feb. 04, 2021

Corporate Participants:

Peter Dannenbaum — Vice President, Investor Relations

Kenneth C. Frazier — Chairman of the Board and Chief Executive Officer

Robert M. Davis — Executive Vice President, Global Services, and Chief Financial Officer

Dean Y. Li — Executive Vice President and President, Merck Research Laboratories

Michael T. Nally — Executive Vice President and Chief Marketing Officer


Seamus Fernandez — Guggenheim Partners — Analyst

Andrew Baum — Citi — Analyst

Terence Flynn — Goldman Sachs — Analyst

Chris Schott — JPMorgan — Analyst

Louise Chen — Cantor — Analyst

David Risinger — Morgan Stanley — Analyst

Daina Graybosch — SVB Leerink — Analyst

Umer Raffat — Evercore ISI — Analyst

Steve Scala — Cowen — Analyst

Navin Jacob — UBS — Analyst

Gregg Gilbert — Truist — Analyst

Mara Goldstein — Mizuho — Analyst

To read the full earnings call transcript, click here

Most Popular

IPO Alert: Here’s what to look for when CaliberCos goes public

The massive slowdown in the IPO market continued in the second half as the challenges posed by high inflation and interest rate hikes weighed on investor confidence. Meanwhile, there is

CarMax (KMX) Stock: Does the current dip offer a buying opportunity?

The automotive sector is one of the worst affected by the combination of high inflation and rising interest rates. Consumers have become more cautious and are prioritizing their purchases with

Ultimax Digital gears up for $10mln IPO. Here’s all you need to know

The IPO market has witnessed muted activity this year, and things don’t seem to have improved in the second half. The upcoming public listing of video game technology firm Ultimax

Add Comment
Viewing Highlight